These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1286980)

  • 1. Cytotoxic flow-cytometric crossmatches (flow-tox): a comparison with conventional cytotoxicity crossmatch techniques.
    Wetzsteon PJ; Head MA; Fletcher LM; Lye WC; Norman DJ
    Hum Immunol; 1992 Oct; 35(2):93-9. PubMed ID: 1286980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminex-based virtual crossmatching for renal transplantation in South Africa.
    Worsley CM; Mayne ES; Suchard MS
    S Afr Med J; 2011 Dec; 102(1):40-3. PubMed ID: 22273137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossmatch procedures used in organ transplantation.
    Gebel HM; Lebeck LK
    Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Cytotoxic Flow Cytometric Cross Match With Complement Dependent Lymphocytotoxicity and Flow Cytometric Cross Match in Renal Transplant Patients.
    Bilgen T; Canbakan M; Şahin G; Titiz Mİ
    Transplant Proc; 2019 May; 51(4):1021-1023. PubMed ID: 31101163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image cytometry as an alternative to flow cytometry for the transplant histocompatibility crossmatch assay.
    Ramon DS; Franks T; Jaramillo A; Paradis BD; Chan LL
    HLA; 2019 Jun; 93(6):436-444. PubMed ID: 30838802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.
    Christiaans MH; Overhof R; ten Haaft A; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1996 Nov; 62(9):1341-7. PubMed ID: 8932282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength.
    Ellis TM; Schiller JJ; Roza AM; Cronin DC; Shames BD; Johnson CP
    Hum Immunol; 2012 Jul; 73(7):706-10. PubMed ID: 22537747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
    Saw CL; Bray RA; Gebel HM
    Cytometry B Clin Cytom; 2008 Sep; 74(5):287-94. PubMed ID: 18454488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplant immuno-diagnostics: crossmatch and antigen detection.
    South AM; Grimm PC
    Pediatr Nephrol; 2016 Jun; 31(6):897-905. PubMed ID: 26139577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching.
    Karuppan SS; Lindholm A; Möller E
    Transplantation; 1992 Mar; 53(3):666-73. PubMed ID: 1549863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of crossmatch results obtained by ELISA, flow cytometry, and conventional methodologies.
    Pelletier RP; Adams PW; Hennessy PK; Orosz CG
    Hum Immunol; 1999 Sep; 60(9):855-61. PubMed ID: 10527393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
    Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
    Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.
    Alheim M; Paul PK; Hauzenberger DM; Wikström AC
    Hum Immunol; 2015 Nov; 76(11):849-57. PubMed ID: 26429307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using real data for a virtual crossmatch.
    Zachary AA; Sholander JT; Houp JA; Leffell MS
    Hum Immunol; 2009 Aug; 70(8):574-9. PubMed ID: 19527762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.